Biopharmaceuticals Market

A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources?human, animal, plant, fungal, or microbial.

Biopharmaceuticals Market contains market size and forecasts of Biopharmaceuticals in Global, including the following market information:

Global Biopharmaceuticals Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Biopharmaceuticals market was valued at 33340 million in 2021 and is projected to reach US$ 55870 million by 2028, at a CAGR of 7.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Monoclonal Antibodies Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Biopharmaceuticals include Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biopharmaceuticals companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Biopharmaceuticals Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Biopharmaceuticals Market Segment Percentages, by Type, 2021 (%)

Monoclonal Antibodies

Interferon

Colony-Stimulating Factor

Erythropoietin

Insulin

Vaccines

Growth Hormones

Others

Global Biopharmaceuticals Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Biopharmaceuticals Market Segment Percentages, by Application, 2021 (%)

Tumor

Diabetes

Cardiovascular

Hemophilia

Others

Global Biopharmaceuticals Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Biopharmaceuticals Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Biopharmaceuticals revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Biopharmaceuticals revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Roche

Amgen

AbbVie

Sanofi-Aventis

Johnson & Johnson

Pfizer

Novo Nordisk

Eli Lilly

Novartis

Merck

Sun

3sbio

Changchun High Tech

CP Guojian

Biotech

Gelgen

Innovent

Dong Bao

Ganlee

United Laboratories

SANDOZ (NOVARTIS)

Teva Pharmaceutical

Hospira ?Pfizer?

MYLAN

Sun pharma